Protein Kinase C θ Affects Ca2+ Mobilization and NFAT Activation in Primary Mouse T Cells
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Protein kinase C (PKC)θ is an established component of the immunological synapse and has been implicated in the control of AP-1 and NF-κB. To study the physiological function of PKCθ, we used gene targeting to generate a PKCθ null allele in mice. Consistently, interleukin 2 production and T cell proliferative responses were strongly reduced in PKCθ-deficient T cells. Surprisingly, however, we demonstrate that after CD3/CD28 engagement, deficiency of PKCθ primarily abrogates NFAT transactivation. In contrast, NF-κB activation was only partially reduced. This NFAT transactivation defect appears to be secondary to reduced inositol 1,4,5-trisphosphate generation and intracellular Ca2+ mobilization. Our finding suggests that PKCθ plays a critical and nonredundant role in T cell receptor–induced NFAT activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. Impaired T cell activation in PKCθD/D mice. Proliferative responses of purified mature CD3+ T cells of wild-type (wt), PKCθΔ/+, and PKCθΔ/Δ. After incubation with medium alone and (A) various stimuli such as anti-CD3 (96-well plates were precoated with a concentration of 10 μg ml−1), with or without 1 μg ml−1 soluble anti-CD28, 40 units ml−1 human, recombinant IL-2, or (B) 10 ng ml−1 PDBu and ionomycin (at a range from 50 to 500 ng ml−1, as indicated) for 48 h, cultures were pulsed for 16 h with 1 μCi [3H]thymidine per well and cells were then harvested and analyzed using standard procedures. Results shown are the mean ± SD [3H]thymidine incorporation of at least five independent experiments.](https://figures.cochat.ai/paper-figures/d52279f8e8b84388b474744c5cd3c37a/protein-kinase-c-affects-ca2-mobilization-and-nfat-activation-in-primary-mouse-t-figure-2.jpg)
![Figure 3. Impaired IL-2 secretion in PKCθD/D mice. IL-2 cytokine secretion responses of (A) purified mature CD3+ T cells of wild-type+/+, PKCθΔ/+, and PKCθΔ/Δ. IL-2 concentration in the supernatants of culture treated with various stimuli: medium, anti-CD3 (precoated with a concentration of 10 μg ml−1), 1 μg ml−1 soluble anti-CD28, 10 ng ml−1 PDBu, and 1 μg ml−1 ionomycin, as indicated. IL-2 produced from the cultures was measured by quantifying the proliferation of the IL-2–dependent indicator cell line CTLL-2. Cells were then harvested and analyzed using standard procedures. (B) For the mixed lymphocyte reaction assays, purified mature CD3+ T cells of wild-type+/+ and PKCθΔ/Δ littermates were mixed in duplicates at various densities with mitomycin C–treated splenocytes from BALB/c mice, as indicated. After 48 h of growth, the cells were pulsed for 16 h with 1 μCi [3H]thymidine. Results shown are the mean ± SD [3H]thymidine incorporation of at least four independent experiments.](https://figures.cochat.ai/paper-figures/9874940214374e97b32be711d9013a20/protein-kinase-c-affects-ca2-mobilization-and-nfat-activation-in-primary-mouse-t-figure-3.jpg)



![Figure 7. PKCθ is required for normal TCR-driven calcium mobilization but not for ERK activation. (A) Purified mature CD3+ T cells (purified from pooled spleen and lymph nodes) were loaded with Fura-2 and monitored for changes in intracellular-free calcium [Ca2+]i. CD3 cross-linking was induced by streptavidin and direct Ca2+ influx with ionomycin. (B and C) Ca2+ signaling patterns from four representative experiments performed in duplicates are statistically analyzed. Slope (B, nM/s) and plateau (C, nM) of intracellular Ca2+ varied significantly in PKCθ-deficient cells (P < 0.01). (D) Graphs showing the mean levels of IP3 stimulated by cross-linking of CD3 as above for 0, 30, and 60 s. Detected IP3 levels ranged from 0.2 pmol/107 cells (unstimulated cells) to 0.8 pmol/107 cells (wild-type stimulated cells). Results shown are the mean ± SD of at least three independent experiments. (E) Total cell lysates were immunostained sequentially with anti–phospho-MAPK that detects dually phosphorylated (active) ERK1, ERK2, and anti-ERK1/2 that recognizes pan-ERK. (F) Kinetics of subcellular translocation of endogenous PKC isotypes in Jurkat T cells as indicated. The cell fractions are defined as the soluble (s, cytosol) fraction, the particulate (pt, predominantly plasma membrane) fraction, and the NP-40 nonsoluble fraction (ns, predominantly cytoskeleton, detergents insoluble membrane domains). As internal control for cell fractionation, immunostaining of p59fyn predominantly recognized the particulate fraction.](https://figures.cochat.ai/paper-figures/3897846418384acdbb904d03a955197b/protein-kinase-c-affects-ca2-mobilization-and-nfat-activation-in-primary-mouse-t-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“PKC theta, another isoform of PKC, showed tumor‐suppressive effects by inducing immune suppression within the TME by controlling CTLA4‐mediated regulatory T‐cell function [117, 118, 119].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [117]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., et al. (2000) · Nature · doi:10.1038/35006090 · Cited by 892
Partners in transcription: NFAT and AP-1
Macián, F., López-Rodríguez, C., & Rao, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204386 · Cited by 766
Generic Signals and Specific Outcomes
Crabtree, G. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80571-1 · Cited by 731
Transcriptional regulation of the IL-2 gene
Jain, J. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80107-3 · Cited by 565
Selective modulation of protein kinase C-Θ during T-cell activation
Monks, C. R. F., Kupfer, H., Tamir, I., Barlow, A., & Kupfer, A. (1997) · Nature · doi:10.1038/385083a0 · Cited by 552
Valitutti, S., Dessing, M., Aktories, K., Gallati, H., & Lanzavecchia, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.577 · Cited by 531
Cited by
Items 101–200 of 339
Trushin, S. A., Bren, G. D., Asin, S., Pennington, K. N., Payá, C. V., & Badley, A. D. (2005) · Journal of Virology · doi:10.1128/jvi.79.15.9821-9830.2005 · Cited by 52
Dynamics of Glucose-Induced Localization of PKC Isoenzymes in Pancreatic β-Cells
Warwar, N., Efendić, S., Östenson, C., Haber, E. P., Cerasi, E., & Nesher, R. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0001 · Cited by 51
Essential role of the T cell–specific adapter protein in the activation of LCK in peripheral T cells
Martí, F., Garcia, G. G., Lapinski, P. E., MacGregor, J. N., & King, P. D. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051637 · Cited by 51
NF-κB family of transcription factors: Biochemical players of CD28 co-stimulation
Tuosto, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.09.005 · Cited by 55
Jimenez, J., Boyall, D., Brenchley, G., Collier, P. N., Davis, C. J., Fraysse, D., Keily, S. B., Henderson, J. L., Miller, A., Pierard, F. Y. T. M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301465a · Cited by 51
Rokosz, L. L., Beasley, J. R., Carroll, C. D., Lin, T. H., Zhao, J., Appell, K. C., & Webb, M. L. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.883 · Cited by 51
Saibil, S. D., Jones, R. G., Deenick, E. K., Liadis, N., Elford, A. R., Vainberg, M. G., Baerg, H., Woodgett, J. R., Gerondakis, S., & Ohashi, P. S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2932 · Cited by 59
Madaro, L., Marrocco, V., Fiore, P. F., Aulino, P., Smeriglio, P., Adamo, S., Molinaro, M., & Bouché, M. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-10-0821 · Cited by 49
Phosphorylation of CARMA1: The Link(er) to NF-κB Activation
Rueda, D., & Thome, M. (2005) · Immunity · doi:10.1016/j.immuni.2005.11.007 · Cited by 48
Brummer, G., Fang, W. B., Smart, C., Zinda, B., Alissa, N., Berkland, C. J., Miller, D., & Cheng, N. (2019) · Oncogene · doi:10.1038/s41388-019-1141-7 · Cited by 50
Ma, J., Ding, Y. P., Fang, X., Wang, R., & Sun, Z. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102979 · Cited by 47
PKCθ cooperates with PKCα in alloimmune responses of T cells in vivo
Gruber, T., Hermann‐Kleiter, N., Pfeifhofer‐Obermair, C., Lutz‐Nicoladoni, C., Thuille, N., Letschka, T., Barsig, J., Baudler, M., Li, J., Metzler, B., et al. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.030 · Cited by 50
Self-citationCole, D. C., Asselin, M., Brennan, A., Czerwiński, R., Ellingboe, J. W., Fitz, L. J., Greco, R., Huang, X., Joseph‐McCarthy, D., Kelly, M. F., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800214a · Cited by 46
Protein kinase C-theta in platelet activation
Cohen-Schwartz, S., Braiman, A., Shubinsky, G., & Isakov, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.09.014 · Cited by 51
George, D. M., Breinlinger, E. C., Friedman, M., Zhang, Y., Wang, J., Argiriadi, M. A., Bansal‐Pakala, P., Barth, M., Duignan, D. B., Honoré, P., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500669m · Cited by 46
Genetic Analysis of the Role of Protein Kinase Cθ in Platelet Function and Thrombus Formation
Hall, K. J., Harper, M. T., Gilio, K., Cosemans, J. M. E. M., Heemskerk, J. W. M., & Poole, A. W. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003277 · Cited by 46
Protein Kinase C θ Is Not Essential for T-Cell-Mediated Clearance of Murine Gammaherpesvirus 68
Giannoni, F., Lyon, A. B., Wareing, M. D., Dias, P. B., & Sarawar, S. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.11.6808-6813.2005 · Cited by 44
Overexpression of Ste20-Related Proline/Alanine-Rich Kinase Exacerbates Experimental Colitis in Mice
Yan, Y., Laroui, H., Ingersoll, S. A., Ayyadurai, S., Charania, M., Yang, S., Dalmasso, G., Obertone, T. S., Nguyen, H., Sitaraman, S. V., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002910 · Cited by 44
Advances in immunosuppression for renal transplantation
Dürrbach, A., François, H., Beaudreuil, S., Jacquet, A., & Charpentier, B. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.233 · Cited by 47
Cutting Edge: Inhibition of T Cell Activation by TIM-2
Knickelbein, J. E., de Souza, A. J., Tosti, R., Narayan, P., & Kane, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.4966 · Cited by 45
Protein Kinase C θ Plays a Fundamental Role in Different Types of Chronic Colitis
Nagahama, K., Ogawa, A., Shirane, K., Shimomura, Y., Sugimoto, K., & Mizoguchi, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.11.005 · Cited by 43
Kingeter, L. M., & Schaefer, B. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6244 · Cited by 44
Involvement of distinct PKC gene products in T cell functions
Pfeifhofer‐Obermair, C., Thuille, N., & Baier, G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00220 · Cited by 45
Self-citationProtein Kinase C-theta Inhibitors: A Novel Therapy for Inflammatory Disorders
Chand, S., Mehta, N., Bahia, M. S., Dixit, A., & Silakari, O. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802651625 · Cited by 46
Puente, L. G., He, J., & Ostergaard, H. L. (2006) · European Journal of Immunology · doi:10.1002/eji.200535277 · Cited by 41
Oxidized ATP inhibits T‐cell‐mediated autoimmunity
Lang, P. A., Merkler, D., Funkner, P., Shaabani, N., Meryk, A., Krings, C., Barthuber, C., Recher, M., Brück, W., Häussinger, D., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939838 · Cited by 40
Protein kinase C inhibitors for immune disorders
Altman, A., & Kong, K. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.05.008 · Cited by 40
Hermann‐Kleiter, N., Thuille, N., Pfeifhofer‐Obermair, C., Gruber, T., Schäfer, M., Zitt, C., Hatzelmann, A., Schudt, C., Leitges, M., & Baier, G. (2006) · Blood · doi:10.1182/blood-2005-10-4044 · Cited by 40
Self-citationClavijo, P. E., & Frauwirth, K. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100793 · Cited by 42
Li, M., Jia, M., Yang, L., Jiang, H., Lanuza, M. A., González, C. M., & Nelson, P. G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3930-03.2004 · Cited by 39
Protein Kinase C-θ Is Required for NK Cell Activation and In Vivo Control of Tumor Progression
Aguiló, J. I., Garaude, J., Pardo, J., Villalba, M., & Anel, A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801820 · Cited by 40
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
Gao, Y., Hu, S., Li, R., Jin, S., Liu, F., Liu, X., Li, Y., Yan, Y., Liu, W., Gong, J., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164793 · Cited by 41
The Critical Role of Protein Kinase C-θ in Fas/Fas Ligand-Mediated Apoptosis
Manicassamy, S., & Sun, Z. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.1.312 · Cited by 38
The Novel PKCθfrom Benchtop to Clinic
Hage‐Sleiman, R., Hamze, A. B., Reslan, L., Kobeissy, H., & Dbaibo, G. S. (2015) · Journal of Immunology Research · doi:10.1155/2015/348798 · Cited by 40
Protein Kinase C-θ (PKC-θ) in Natural Killer Cell Function and Anti-Tumor Immunity
Anel, A., Aguiló, J. I., Catalán, E., Garaude, J., Rathore, M. G., Pardo, J., & Villalba, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00187 · Cited by 47
Tan, S., Zhou, T., Wang, W., Jin, Y., Wang, X., Geng, X., Luo, J., Yuan, Z., Yang, Y., Shi, H., et al. (2018) · Molecular Genetics and Genomics · doi:10.1007/s00438-018-1443-4 · Cited by 38
PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim
Byerly, J. H., Port, E. R., & Irie, H. Y. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01302-w · Cited by 39
Pardo, J. (2003) · International Immunology · doi:10.1093/intimm/dxg141 · Cited by 36
Matz, M., Naik, M. G., Mashreghi, M., Glander, P., Neumayer, H., & Budde, K. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.540238 · Cited by 35
Ozay, E. I., González‐Pérez, G., Torres, J. A., Vijayaraghavan, J., Lawlor, R. G., Sherman, H. L., Garrigan, D. T., Burnside, A., Osborne, B. A., Tew, G. N., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.177 · Cited by 36
Perspectives on PKC? in T cell activation
Sedwick, C. E., & Altman, A. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.01.007 · Cited by 37
A Critical Role for Protein Kinase C-θ-Mediated T Cell Survival in Cardiac Allograft Rejection
Manicassamy, S., Yin, D., Zhang, Z., Molinero, L. L., Alegre, M., & Sun, Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.513 · Cited by 37
Sumoza‐Toledo, A., Eaton, A. D., & Sarukhan, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.5779 · Cited by 34
2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes
van Eis, M. J., Evenou, J.-P., Floersheim, P., Gaul, C., Cowan‐Jacob, S. W., Monovich, L. G., Rummel, G., Schüler, W., Stark, W., Strauss, A., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.025 · Cited by 33
Czerwiński, R., AULABAUGH, A. E., Greco, R. M., Olland, S., Malakian, K., Wolfrom, S., Lin, L., Kriz, R., Stahl, M., Huang, Y., et al. (2005) · Biochemistry · doi:10.1021/bi050608q · Cited by 33
Itk: The Rheostat of the T Cell Response
Grasis, J. A., & Tsoukas, C. D. (2011) · Journal of Signal Transduction · doi:10.1155/2011/297868 · Cited by 32
Zhang, W., Le, L., Ahmad, G., Molehin, A. J., Siddiqui, A. J., Torben, W., Karmakar, S., Rojo, J. U., Sennoune, S. R., Lazarus, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01246 · Cited by 34
Lin, H., Sue, Y., Chou, Y., Cheng, C., Chang, C., Li, H., Chen, C., & Juan, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00989.x · Cited by 31
Marrocco, V., Fiore, P. F., Benedetti, A., Pisu, S., Rizzuto, E., Musarò, A., Madaro, L., Lozanoska‐Ochser, B., & Bouché, M. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.001 · Cited by 32
Protein kinase D2: a versatile player in cancer biology
Azoitei, N., Cobbaut, M., Becher, A., Lint, J. V., & Seufferlein, T. T. W. (2017) · Oncogene · doi:10.1038/s41388-017-0052-8 · Cited by 30
Rottlerin inhibits human T cell responses
Springael, C., Thomas, S., Rahmouni, S., Vandamme, A., Goldman, M., Willems, F., & Vosters, O. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.034 · Cited by 30
Involvement of GATA3 in Protein Kinase C θ‐induced Th2 cytokine expression
Stevens, L. M., Htut, T. M., White, D. M., Li, X., Hanidu, A., Stearns, C. D., Labadia, M. E., Li, J., Brown, M. L., & Yang, J. (2006) · European Journal of Immunology · doi:10.1002/eji.200636400 · Cited by 33
Kane, L., Mollenauer, M. N., & Weiss, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5441 · Cited by 34
Ca2+ as a therapeutic target in cancer
Gross, S., Mallu, P., Joshi, H., Schultz, B. M., Go, C. K., & Soboloff, J. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.05.003 · Cited by 32
In and out of the bull's eye: protein kinase Cs in the immunological synapse
Kong, K., & Altman, A. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.01.002 · Cited by 29
Protein Kinase C-θ Is Required for Efficient Positive Selection
Morley, S. C., Weber, K. S., Kao, H., & Allen, P. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4696 · Cited by 30
Katoh, T., Takai, T., Yukawa, T., Tsukamoto, T., Watanabe, E., Mototani, H., Arita, T., Hayashi, H., Nakagawa, H., Klein, M. G., et al. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.04.008 · Cited by 29
Weckbecker, G., Pally, C., Beerli, C., Burkhart, C., Wieczorek, G., Metzler, B., Morris, R. E., Wagner, J., & Bruns, C. (2009) · Transplant International · doi:10.1111/j.1432-2277.2009.01015.x · Cited by 32
Wiskott-Aldrich Syndrome Protein: Roles in Signal Transduction in T Cells
Ngoenkam, J., Paensuwan, P., Wipa, P., Schamel, W. W. A., & Pongcharoen, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.674572 · Cited by 33
Stahelin, R. V., Kong, K., Raha, S., Tian, W., Melowic, H. R., Ward, K. E., Murray, D., Altman, A., & Cho, W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391557 · Cited by 28
Protein kinase C isozymes as potential therapeutic targets in immune disorders
Lee, M. R., Duan, W., & Tan, S. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.535 · Cited by 28
Role of T cell–nuclear factor κB in transplantation
Molinero, L. L., & Alegre, M. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.07.005 · Cited by 30
D'Andrea, M., Pisaniello, A., Serra, C., Senni, M., Castaldi, L., Molinaro, M., & Bouché, M. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20585 · Cited by 28
Impaired anti-leukemic immune response in PKCθ-deficient mice
Garaude, J., Kaminski, S., Charni, S., Aguilò, J. I., Jacquet, C., Plays, M., Hernández, J., Rodríguez, F., Hipskind, R. A., Anel, A., et al. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.03.016 · Cited by 29
Ameliorated ConA-Induced Hepatitis in the Absence of PKC-theta
Fang, X., Wang, R., Ma, J., Ding, Y. P., Shang, W., & Sun, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031174 · Cited by 27
Bertram, A., Zhang, H., von Vietinghoff, S., de Pablo, C., Haller, H. G., Shushakova, N., & Ley, K. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101651 · Cited by 30
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways
Despouy, G., Joiner, M., Toriellec, É. L., Weil, R., & Stern, M. (2007) · Blood · doi:10.1182/blood-2006-11-059501 · Cited by 26
Gruber, T., Pfeifhofer‐Obermair, C., & Baier, G. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.04.008 · Cited by 25
Self-citationActivation of T Cells: Releasing the Brakes by Proteolytic Elimination of Cbl-b
Schmitz, M. L. (2009) · Science Signaling · doi:10.1126/scisignal.276pe38 · Cited by 27
Nika, K., Charvet, C., Williams, S., Tautz, L., Bruckner, S. R., Rahmouni, S., Bottini, N., Schoenberger, S. P., Baier, G., Altman, A., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.5.1806-1816.2006 · Cited by 25
Self-citationTwo opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells
Fourmentraux-Neves, E., Jalil, A., Rocha, S. D., Pichon, C., Chouaïb, S., Bismuth, G., & Caignard, A. (2008) · Blood · doi:10.1182/blood-2007-12-127779 · Cited by 27
Bermejo, M., López‐Huertas, M. R., Hedgpeth, J., Mateos, E., Rodríguez-Mora, S., Maleno, M. J., Plana, M., Swindle, J., Alcamí, J., & Coiras, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.009 · Cited by 27
PKC-θ is a Drug Target for Prevention of T Cell-Mediated Autoimmunity and Allograft Rejection
Kwon, M.-J., Wang, R., Ma, J., & Sun, Z. (2010) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530311006040367 · Cited by 28
Requirement of Calcineurin Aβ for the Survival of Naive T Cells
Manicassamy, S., Gupta, S., Huang, Z., Molkentin, J. D., Shang, W., & Sun, Z. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.106 · Cited by 27
Negative regulation of T cell receptor signals
Rangachari, M. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.007 · Cited by 24
Taurine and proliferation of lymphocytes in physically restrained rats
Fazzino, F., Obregón, F., & Lima, L. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-s1-s24 · Cited by 25
Lee, M. D., Bingham, K. N., Mitchell, T. Y., Meredith, J. L., & Rawlings, J. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.10.015 · Cited by 25
Intervention of PKC-θ as an immunosuppressive regimen
Sun, Z. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00225 · Cited by 25
Mechanisms regulating the development and function of natural regulatory T cells
Gupta, S., Shang, W., & Sun, Z. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0015-4 · Cited by 28
Huang, H., Tang, Q., Chu, H., Jiang, J., Zhang, H., Hao, W., & Wei, X. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.02.006 · Cited by 22
Collier, P. N., Twin, H. C., Knegtel, R. M. A., Boyall, D., Brenchley, G., Davis, C. J., Keily, S. B., Mak, C., Miller, A., Pierard, F. Y. T. M., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00134 · Cited by 22
Park, J., Chung, S., Kim, S. W., & Kim, T. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.08.001 · Cited by 22
PKCθ is required for the activation of human T lymphocytes induced by CD43 engagement
del Río, R., Rincón, M., Layseca‐Espinosa, E., Fierro, N. A., Rosenstein, Y., & Pedraza‐Alva, G. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.006 · Cited by 22
Protein Kinase C θ Regulates the Phenotype of Murine CD4+ Th17 Cells
Wachowicz, K., Hermann‐Kleiter, N., Meisel, M., Siegmund, K., Thuille, N., & Baier, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096401 · Cited by 21
Self-citationNovel Molecular Targets in the Search for Anti-Inflammatory Agents
Schmitz, M. L., & Bacher, S. (2005) · Phytochemistry Reviews · doi:10.1007/s11101-005-3260-8 · Cited by 26
Deltex1 Promotes Protein Kinase Cθ Degradation and Sustains Casitas B-Lineage Lymphoma Expression
Hsu, T.-S., Hsiao, H.-W., Wu, P.-J., Liu, W., & Lai, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301416 · Cited by 21
Lee, H., Kim, Y., Na, B.-R., Kim, H., Choi, E., Han, W., Choi, H.-K., Lee, S. H., & Jun, C. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.11.001 · Cited by 21
Sebald, A., Mattioli, I., & Schmitz, M. L. (2004) · European Journal of Immunology · doi:10.1002/eji.200425024 · Cited by 21
Lee, J. Y., Choi, A. Y., Oh, Y. T., Choe, W., Yeo, E., Ha, J., & Kang, I. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.01.015 · Cited by 21
Page, K. M., Chaudhary, D., Goldman, S. J., & Kasaian, M. T. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107745 · Cited by 20
T Cell Activation Leads to Protein Kinase Cθ-Dependent Inhibition of TGF-β Signaling
Giroux, M., Delisle, J., O’Brien, A., Hébert, M., & Perreault, C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000137 · Cited by 20
Thuille, N., Wachowicz, K., Hermann‐Kleiter, N., Kaminski, S., Fresser, F., Lutz‐Nicoladoni, C., Leitges, M., Thome, M., Massoumi, R., & Baier, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053709 · Cited by 19
Self-citationXie, J.-J., Han, X., Zhao, C.-S., Canonigo-Balancio, A. J., Yates, J. R., Li, Y., Lillemeier, B. F., & Altman, A. (2019) · Science Signaling · doi:10.1126/scisignal.aar3349 · Cited by 19
PKCθ cooperates with atypical PKCζ and PKCι in NF-κB transactivation of T lymphocytes
Gruber, T., Fresser, F., Jenny, M., Überall, F., Leitges, M., & Baier, G. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.05.003 · Cited by 19
Self-citationRaf-1 and B-Raf promote protein kinase C θ interaction with BAD
Hindley, A. D., & Kölch, W. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.004 · Cited by 21
Effects of the new immunosuppressive agent AEB071 on human immune cells
Matz, M., Weber, U., Mashreghi, M., Lorkowski, C., Ladhoff, J., Kramer, S., Neumayer, H., & Budde, K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp775 · Cited by 18
Jiang, L., Chi, C., Yuan, F., Lu, M., Hu, D., Wang, L., & Liu, X. (2022) · Chinese Medicine · doi:10.1186/s13020-022-00599-3 · Cited by 19
Ohayon, A., Golenser, J., Sinay, R., Tamir, A., Altman, A., Pollack, Y., & Isakov, N. (2010) · Infection and Immunity · doi:10.1128/iai.00465-10 · Cited by 18
Role of PKCtheta in macrophage-mediated immune response to Salmonella typhimurium infection in mice
Pfeifhofer‐Obermair, C., Albrecht-Schgoer, K., Peer, S., Nairz, M., Siegmund, K., Klepsch, V., Haschka, D., Thuille, N., Hermann‐Kleiter, N., Gruber, T., et al. (2016) · Cell Communication and Signaling · doi:10.1186/s12964-016-0137-y · Cited by 18
Self-citationProtein kinase C beta is dispensable for TCR-signaling
Thuille, N., Gruber, T., Böck, G., Leitges, M., & Baier, G. (2004) · Molecular Immunology · doi:10.1016/s0161-5890(04)00071-9 · Cited by 17
Self-citation
Metadata
- Authors
- Pfeifhofer, C., Kofler, K., Gruber, T., Ghaffari Tabrizi, N., Lutz, C., Maly, K., Leitges, M., & Baier, G.
- Affiliations
- 1Institute of Medical Biology and Human Genetics, University of Innsbruck, A-6020 Innsbruck, Austria
- Universität Innsbruck (AT)
- Max Planck Society (DE)
- Corresponding author
- Baier, Gottfried
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-06-02
- Volume
- 197
- Issue
- 11
- Pages
- 1525-1535
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2193906
- OpenAlex
- W2153227360
- Cited by
- 326
- References
- 46
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 8 · 2021: 6 · 2020: 13 · 2019: 10 · 2018: 5 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 18 · 2013: 14 · 2012: 19
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- protein kinase C theta, NFAT activation, calcium mobilization, inositol 1,4,5-trisphosphate, T cell receptor signaling, NF-κB, IL-2 production, T cell proliferation, immunological synapse, anti-CD3/CD28 stimulation
- MeSH terms
- Protein Kinase C-theta, Animals, Base Sequence, Cells, Cultured, DNA, DNA-Binding Proteins, Isoenzymes, Lymphocyte Activation, Nuclear Proteins, Protein Kinase C, T-Lymphocytes, Transcription Factors, Transcriptional Activation, NF-kappa B, Receptor-CD3 Complex, Antigen, T-Cell, Mice, Knockout, Calcium Signaling, NFATC Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.